RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,680,739 | -33.0% | 27,904,963 | 0.0% | 1.93% | -27.6% |
| Q2 2023 | $350,486,335 | -23.7% | 27,904,963 | 0.0% | 2.67% | -29.3% |
| Q1 2023 | $459,594,741 | +10.2% | 27,904,963 | 0.0% | 3.78% | +8.6% |
| Q4 2022 | $416,900,147 | -33.2% | 27,904,963 | 0.0% | 3.48% | -27.2% |
| Q3 2022 | $624,234,000 | +33.6% | 27,904,963 | 0.0% | 4.78% | +28.6% |
| Q2 2022 | $467,408,000 | -44.0% | 27,904,963 | 0.0% | 3.71% | -6.2% |
| Q1 2022 | $835,196,000 | -2.5% | 27,904,963 | 0.0% | 3.96% | +58.6% |
| Q4 2021 | $856,961,000 | -2.6% | 27,904,963 | 0.0% | 2.50% | -8.4% |
| Q3 2021 | $879,843,000 | -13.8% | 27,904,963 | 0.0% | 2.73% | +36.3% |
| Q2 2021 | $1,021,042,000 | +5.8% | 27,904,963 | 0.0% | 2.00% | +19.8% |
| Q1 2021 | $964,675,000 | -16.8% | 27,904,963 | 0.0% | 1.67% | -64.2% |
| Q4 2020 | $1,159,730,000 | -2.4% | 27,904,963 | 0.0% | 4.67% | -54.2% |
| Q3 2020 | $1,188,472,000 | – | 27,904,963 | – | 10.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |